ASPIRA PATHLAB & DIAGNOSTICS Financial Statement Analysis
|
||
|
The Revenues of ASPIRA PATHLAB & DIAGNOSTICS have increased by 66.60% YoY .
The Earnings Per Share (EPS) of ASPIRA PATHLAB & DIAGNOSTICS has increased by Positive YoY. |
||
ASPIRA PATHLAB & DIAGNOSTICS Last 5 Annual Financial Results
[BOM: 540788]
| Consolidated | Mar2025 | Mar2024 |
|---|---|---|
| Operating Income | ₹22 Cr | ₹13 Cr |
| Expenses | ₹18 Cr | ₹14 Cr |
| Operating Profit (Excl OI) | ₹3.53 Cr | ₹-1.19 Cr |
| Other Income | ₹0.39 Cr | ₹0.42 Cr |
| Interest | ₹0.35 Cr | ₹0.37 Cr |
| Depreciation | ₹1.49 Cr | ₹1.54 Cr |
| Profit Before Tax | ₹2.02 Cr | ₹-2.67 Cr |
| Profit After Tax | ₹2.02 Cr | ₹-2.67 Cr |
| Consolidated Net Profit | ₹2.02 Cr | ₹-2.67 Cr |
| Earnings Per Share (Rs) | ₹1.97 | ₹-2.60 |
| PAT Margin (%) | 9.19 | -20.24 |
| ROE(%) | 18.13 | -26.34 |
| ROCE(%) | 19.27 | -20.54 |
| Total Debt/Equity(x) | 0.10 | 0.11 |
Key Financials |
||
| Market Cap | : | ₹ 93.9 Cr |
| Revenue (TTM) | : | ₹ 22.6 Cr |
| Net Profit(TTM) | : | ₹ 2.6 Cr |
| EPS (TTM) | : | ₹ 2.5 |
| P/E (TTM) | : | 36.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ASPIRA PATHLAB & DIAGNOSTICS | 1.6% | -19.7% | 51.4% |
| APOLLO HOSPITALS ENTERPRISE | -1% | -2.3% | 13.4% |
| MAX HEALTHCARE INSTITUTE | -1.4% | -7% | -13.2% |
| FORTIS HEALTHCARE | -0.3% | -2.3% | -0.2% |
| ASTER DM HEALTHCARE | 0.9% | -8.7% | 27.6% |
| NARAYANA HRUDAYALAYA | 1% | 0.2% | 10.5% |
| GLOBAL HEALTH | -4.4% | 0.7% | 4.1% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | -2.1% | -5.1% | 3% |
| DR LAL PATHLABS | -1.3% | 1.3% | 14.6% |
ASPIRA PATHLAB & DIAGNOSTICS Revenues
[BOM: 540788]
| Y-o-Y | 66.60 % |
| 5 Yr CAGR | 66.60 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹22 Cr | 66.60 | |
| Mar2024 | ₹13 Cr | - | |
ASPIRA PATHLAB & DIAGNOSTICS Operating Profit
[BOM: 540788]
| Y-o-Y | Positive |
| 5 Yr CAGR | Positive |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.53 Cr | Positive | |
| Mar2024 | ₹-1.19 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | Positive |
| 5 Yr CAGR | Positive |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 16.02% | Positive | |
| Mar2024 | -8.99% | - | |
ASPIRA PATHLAB & DIAGNOSTICS Profit After Tax
[BOM: 540788]
| Y-o-Y | Positive |
| 5 Yr CAGR | Positive |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.02 Cr | Positive | |
| Mar2024 | ₹-2.67 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Positive |
| 5 Yr CAGR | Positive |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 9.19 % | Positive | |
| Mar2024 | -20.24 % | - | |
ASPIRA PATHLAB & DIAGNOSTICS Earnings Per Share (EPS)
[BOM: 540788]
| Y-o-Y | Positive |
| 5 Yr CAGR | Positive |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.97 | Positive | |
| Mar2024 | ₹-2.60 | - | |
ASPIRA PATHLAB & DIAGNOSTICS Return on Capital Employed (ROCE)
[BOM: 540788]
| Y-o-Y | Positive |
| 5 Yr CAGR | Positive |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 19.27% | Positive | |
| Mar2024 | -20.54% | - | |
ASPIRA PATHLAB & DIAGNOSTICS Share Price vs Sensex
| Current Share Price | : | ₹91.2 |
| Current MarketCap | : | ₹ 93.9 Cr |
| Updated EOD on | : | Sep 02,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASPIRA PATHLAB & DIAGNOSTICS | 1.6% |
-19.7% |
51.4% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
ASPIRA PATHLAB & DIAGNOSTICS related INDICES
You may also like the below Video Courses
FAQ about ASPIRA PATHLAB & DIAGNOSTICS Financials
How the annual revenues of ASPIRA PATHLAB & DIAGNOSTICS have changed ?
The Revenues of ASPIRA PATHLAB & DIAGNOSTICS have increased by 66.60% YoY .
How the Earnings per Share (EPS) of ASPIRA PATHLAB & DIAGNOSTICS have changed?
The Earnings Per Share (EPS) of ASPIRA PATHLAB & DIAGNOSTICS has increased by Positive YoY .
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs FORTIS HEALTHCARE LTD
ASTER DM HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs